Condition
Plasma Cell Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Plasma Cell Disorder clinical trials that are recruiting, at sites in 5 countries (most in United States (4), Germany (1), Hungary (1)). By phase: Phase 1/2 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Plasma Cell Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Subcutaneous daratumumab in the thigh versus the abdomen for adults with plasma cell disorders | Phase 1/2 | Baltimore, Maryland | Recruiting | Jul 20, 2025 |
| Evaluating the risk of blood cancers in firefighters | — | Charlotte, North Carolina | Recruiting | Mar 11, 2025 |
| High Dose Ascorbic Acid for Plasma Cell Disorders | Phase 1 | Little Rock, Arkansas | Recruiting | Mar 15, 2024 |
| Assessing the safety of HDP-101 for patients with relapsed refractory multiple myeloma | Phase 1/2 | Atlanta, Georgia and 23 other locations | Recruiting | May 10, 2021 |
All recruiting trials (4)
-
Subcutaneous daratumumab in the thigh versus the abdomen for adults with plasma cell disorders
This trial tests whether giving subcutaneous daratumumab in the thigh instead of the abdomen is safe and gives similar blood levels in adults with multiple myeloma or AL amyloidosis starting daratumumab.
-
Evaluating the risk of blood cancers in firefighters
This study is testing if firefighters who have been exposed to harmful substances are at a higher risk for blood cancers and related conditions.
-
High Dose Ascorbic Acid for Plasma Cell Disorders
This study is testing whether high doses of vitamin C can help people with relapsed multiple myeloma feel better when combined with a lower dose of a chemotherapy drug and a stem cell transplant.
-
Assessing the safety of HDP-101 for patients with relapsed refractory multiple myeloma
This study is testing a new treatment called HDP-101 to see if it is safe and effective for people with relapsed or refractory multiple myeloma.
Related topics
Quick answers
How many Plasma Cell Disorder clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Germany (1 trial), Hungary (1 trial), Poland (1 trial), Romania (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.